Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466 Buy
+1
New +$420 ﹤0.01% 1553
2026
Q1
Sell
-36
Closed -$15.5K 1428
2025
Q4
$15.5K Sell
36
-86
-70% -$37.4K ﹤0.01% 761
2025
Q3
$54.7K Sell
122
-47
-28% -$21.3K ﹤0.01% 537
2025
Q2
$82.3K Buy
169
+19
+13% +$10.8K 0.01% 466
2025
Q1
$92.6K Sell
150
-103
-41% -$58.5K 0.01% 431
2024
Q4
$134K Hold
253
0.01% 361
2024
Q3
$142K Sell
253
-9
-3% -$5.1K 0.01% 345
2024
Q2
$142K Buy
+262
New +$150K 0.02% 316

Other funds holding CHE

LRI Investments's CHE Position: Q2 2026 in Review

LRI Investments opened a new position in Chemed (CHE) in Q2 2026: 1 share worth $466. The stake represents ﹤0.01% of the portfolio and ranks #1553 among its holdings. This is a return to the name: LRI Investments previously reported a position in CHE as recently as Q4 2025.

LRI Investments first reported a position in CHE in Q2 2024 and has held it in 8 quarters since. The position peaked at $142K in Q2 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • LRI Investments held 1 share of Chemed worth $466 as of Q2 2026.
  • Chemed was a new LRI Investments position in Q2 2026.
  • Chemed made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1553 holding.
  • LRI Investments first reported a position in Chemed in Q2 2024 and has held it in 8 quarters since.
  • LRI Investments's Chemed position peaked at $142K in Q2 2024.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.